Search Results 81-90 of 18579 for Hepatitis D
The purpose of this study is to evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) in participants with chronic genotype 1 or 4 hepatitis C ...
D. Minnesota. Keaveny, Andrew P. M.D.. Florida. Pungpapong, Surakit M.D.. Florida. Razonable, Raymund R. M.D.. Minnesota. Rizza, Stacey A. M.D.. Minnesota ...
D. Minnesota. Razonable, Raymund R. M.D.. Minnesota. Rizza, Stacey A. M.D.. Minnesota. Temesgen, Zelalem M.D.. Minnesota. By Mayo Clinic Staff · Hepatitis C ...
This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study ( ...
This project in the Developmental Research Program of the Mayo Clinic Hepatobiliary SPORE is studying liver cancer associated with hepatitis B virus ...
Focus areas. Dr. Yao focuses his research on the development of new and improved clinical diagnostic tests for viral hepatitis, HIV infection and transplant- ...
"Hepatitis A is highly contagious and affects the liver," says Dr. Rizza. "It's a self-limited infection in contrast to some other viral hepatitis. This means ...
Hepatitis C Screening in Post-Baby Boomer ... Halket D, Dang J, Phadke A, Jayasekera C, Kim WR ... Targeted Electronic Patient Portal Messaging Increases Hepatitis ...
El minuto de Mayo Clinic: El abecé de la hepatitis (The ABCs of hepatitis) ... Lewis Roberts, M.B., Ch.B., Ph.D., senior author of the study. With the ...
Doctors also study the use of antiviral therapy before or after liver transplant for some people with hepatitis C. In addition, doctors conduct research to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.